Crossmark

Intermittent Use of a Short-Course Glucagon-like Peptide-1 Receptor Agonist Therapy Limits Adverse Cardiac Remodeling via Parkin-dependent Mitochondrial Turnover

Crossref DOI link: https://doi.org/10.1038/s41598-020-64924-2

Published Online: 2020-05-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Germano, Juliana de F.

Huang, Chengqun

Sin, Jon

Song, Yang

Tucker, Kyle C.

Taylor, David J. R.

Saadaeijahromi, Hannaneh

Stotland, Aleksandr

Piplani, Honit

Gottlieb, Roberta A.

Mentzer, Robert M. Jr.

Andres, Allen M.
License Information

Text and Data Mining valid from 2020-05-19

Version of Record valid from 2020-05-19
More Information

Article History

Received: 16 September 2019

Accepted: 6 April 2020

First Online: 19 May 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below